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Abstract
Novel microcarriers consisting of calcium phosphate cement and alginate were prepared for use as three-dimensional
scaffolds for the culture and expansion of cells that are effective for bone tissue engineering. The calcium phosphate
cement-alginate composite microcarriers were produced by an emulsification of the composite aqueous solutions mixed
at varying ratios (calcium phosphate cement powder/alginate solution¼ 0.8–1.2) in an oil bath and the subsequent in situ
hardening of the compositions during spherodization. Moreover, a porous structure could be easily created in the solid
microcarriers by soaking the produced microcarriers in water and a subsequent freeze-drying process. Bone mineral-like
apatite nanocrystallites were shown to rapidly develop on the calcium phosphate cement–alginate microcarriers under
moist conditions due to the conversion of the a-tricalcium phosphate phase in the calcium phosphate cement into a
carbonate–hydroxyapatite. Osteoblastic cells cultured on the microspherical scaffolds were proven to be viable, with an
active proliferative potential during 14 days of culture, and their osteogenic differentiation was confirmed by the deter-
mination of alkaline phosphatase activity. The in situ hardening calcium phosphate cement–alginate microcarriers devel-
oped herein may be used as potential three-dimensional scaffolds for cell delivery and tissue engineering of bone.
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Introduction
Spherical particles are gaining increasing interest as the
scaﬀolding matrices for the culture of tissue cells and
for the direct filling of defective bone tissues.1–3
Particulates with sizes of hundreds of micrometers
can provide good substrate conditions for tissue cells
to adhere to and populate on, and further them to
develop into specific tissue forms, consequently healing
the defects.2,3 Biological molecules can also be incorpo-
rated within the spheres to elicit therapeutic eﬃcacy.4,5
Among the compositions developed, bioactive ceramics
have proven to be potential candidate substrates for
bone regeneration. However, those ceramics generally
require high-temperature processing to consolidate and
maintain structural integrity, which, however, is detri-
mental to the incorporation of bioactive molecules and
therapeutics.6,7
In contrast, calcium phosphate cements (CPCs)
self-set to form hardened materials, and the compos-
itions are also biocompatible and eﬀective for
bone-cell functions.8,9 We herein used the CPC as the
precursor for the preparation of microspheres.
Moreover, alginate was combined with CPC in order
to form a sphere particle more eﬀectively. The CPC and
alginate composite system has been demonstrated to be
a useful matrix with its improved mechanical integrity
and bone-cell diﬀerentiation.10,11 The CPC–alginate
microsphere is considered to be properly applied as
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injectable bone fillers either directly or with incorporat-
ing bioactive therapeutics. Moreover, bone progenitor
or stem cells can be cultivated on the spherical scaﬀolds
for the purpose of bone tissue engineering.
While CPC with its in situ hardening property is
considered to solidify at room temperature, the alginate
used together with CPC composition can improve the
CPC’s setting ability and, ultimately, the mechanical
integrity of the microcarriers.12 Alginate is a natural
polymer derived from algae, is non-toxic and tissue-
compatible, and thus has been widely used as a
biomaterial for wound repair and cell encapsulation.13
In particular, the CPC–alginate microcarriers have also
been explored to allow the development of macropores
within the structure to retain large spaces for eﬀective
culture of tissue cells. The processing route to prepare
CPC–alginate microcarriers is described, and the
in vitro bioactive responses are also addressed for use
as bone regeneration materials.
Materials and methods
Preparation and characterization of microcarriers
As the precursor of CPC powder, a-tricalcium phos-
phate was prepared, as described in a previous work.9
In brief, calculated amounts of calcium carbonate and
dicalcium phosphate anhydrous were put in a platinum
crucible and heat-treated at 1400"C for 5 h and then
quenched. About 5% Na2HPO4, either with or without
alginate (Na-alginate, Aldrich), was used as the liquid
phase. The concentration of alginate was 2% or 3%.
The CPC powder and alginate liquid phases were mixed
at varying ratios (CPC powder/alginate liquid¼ 0.8,
0.9, 1.0, 1.1, and 1.2 by weight).
Microcarriers of the CPC–alginate were produced by
means of a water-in-oil emulsification method. The
CPC–alginate mixture of 1ml was dropped into a 60-
ml olive oil bath, while stirring at 380 rpm for about
60min. The stirring speed was determined to produce
spherical microcarriers with sizes in the hundreds of
micrometers range that are appropriate for cell culture.
Furthermore, the stirring time was optimized to enable
the in situ hardening process to form stable microcar-
riers. After stirring, the microcarriers were washed with
ethanol and lyophilized at #60"C using a freeze-dryer.
In order to provide a macroporous structure within the
spheres, the ethanol-treated spheres were soaked in dis-
tilled water for 1min and frozen at #20"C and then
lyophilized at #60"C using a freeze-dryer.
The morphology of the microcarriers was examined
with scanning electron microscopy (SEM, Hitachi S-
3000H), and the size of the microcarriers was evaluated
from the images. The microcarriers were soaked in a
simulated body fluid (which contains 2.5mM Ca2þ,
142mM Naþ, 1.5mM Mg2þ, 5.0mM Kþ, 125.0mM
Cl#, 27.0mM HCO3
#, 1.0mM HPO4
2#, and 0.5mM
SO4
2#) for diﬀerent time periods to examine any
changes in the phase, and the surface morphology
was observed using SEM.14
In vitro cell culture on the microcarriers
The biocompatibility of the CPC–alginate microcar-
riers was briefly examined by the proliferative potential
of the pre-osteoblast cell line (MC3T3-E1).15 The
microcarriers of 30mg were contained in each well of
a 96-well plate, and the cells were seeded at a density of
5% 103 cells/well and then cultured in a-minimal essen-
tial medium supplemented with fetal bovine serum con-
taining antibiotics in a humidified atmosphere of 95%
CO2 at 37
"C.
The cell morphology was examined with SEM after
fixing the cells with glutaraldehyde (2.5%), dehydrating
with a graded series of ethanol, and treating with hex-
amethyldisilazane and gold coating. Cell proliferation
was measured by means of the MTS assay (CellTiter 96
Aqueous One Solution, Promega, USA).15 For the dif-
ferentiation study, osteogenic factors involving 10mM
b-glycerol phosphate and 50 mg/ml l-ascorbic acid were
added to the culture medium. The alkaline phosphatase
activity (ALP), an early osteogenic marker, was deter-
mined, as described in our previous study.16
Experiments were conducted on three replicate sam-
ples. Statistical analysis was performed using
ANOVA. A significant level was considered at p< 0.05.
Results and discussion
The CPC–alginate solutions prepared at diﬀerent ratios
(CPC/alginate¼ 0.8–1.2) were demonstrated to be well-
developed into a spherical form by the water-in-oil
emulsification method. Figure 1(a) shows the SEM
images of the representative CPC–alginate microcar-
riers (CPC/alginate¼ 0.8) at low magnification.
Spherical-shaped particles were well formed, and the
surface was shown to reveal that the CPC particles
were several micrometers in size, which were sur-
rounded with alginate polymeric phase. At high mag-
nification of the representative CPC–alginate
microcarriers (CPC/alginate¼ 0.8, 1.0, and 1.2), as the
powder content (CPC/alginate ratio) increased, the sur-
face morphology became less dense (Figure 1(b–d)).
For all cases, the microcarriers were well-integrated,
which is appropriate for handling in other assays,
such as cell tests.
The size distributions of the CPC–alginate microcar-
riers were assessed from the SEM images and are
shown in Figure 2(a). Microcarriers had sizes of
about 100–500 mm, and the increase in CPC powder
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content increased the microcarrier size (from 183 to
288 mm, on average), as shown in Figure 2(b). This
size range is considered to be appropriate for the cul-
ture of tissue cells upon the spherical substrates target-
ing tissue regeneration purposes.2–4
The process of this sphere formation was designed to
last for 60min, which was based on our previous work
on the observation of setting time of CPC (within an
hour) for the powder-to-liquid ratios used herein.10
Specifically, the self-setting reaction of the CPC is con-
sidered to occur with the alginate solution within the
droplets contained in an oil bath. Because the alginate
becomes cross-linked by the exchange with calcium
ions, the alginate should play some role in the harden-
ing of the CPC-based spheres through reaction with
calcium ions released from the CPC composition.10,11
Therefore, when compared to the pure CPC, the algi-
nate-added CPC has been shown to have better setting
properties, and this positively aﬀects the resultant
mechanical integrity.
The obtained CPC–alginate microcarriers exhibited
the phase transformation of the initial CPC compos-
ition into a hydroxyapatite (HA) phase, a general
reaction in the a-TCP-based cement under moisture
conditions. Figure 3 shows the representative micro-
structural change of the CPC–alginate microcarriers
during immersion in a fluid for 7 days. Low-magnifica-
tion image appeared to show a similar morphological
feature to that without immersion (Figure 3(a)). At
higher magnification, small nanocrystallites completely
covered the surface of the microcarriers (Figure 3(b)).
As shown in the XRD data (Figure 3(c)), the initial
a-TCP phase was transformed into the HA phase
after 7 days of immersion. The nanocrystalline HA
phase produced on the CPC–alginate spheres is con-
sidered to be favorable for the cell and tissue responses.
A feasibility study of the microcarriers was briefly
performed by culturing pre-osteoblastic cells directly
on the developed microcarriers. The SEM cell growth
images on the solid microcarriers were taken at diﬀer-
ent positions and magnifications. Cells exhibited
good adhesion and spreading, with active cytoskel-
etal processes on the surface of microcarriers (Figure
4(a)), and also accumulated at the contact points
of microcarriers bridging them together (Figure 4(b)
and (c)).
Figure 1. SEM morphologies of the CPC/alginate microcarriers. Images were taken at different magnifications (CPC/alginate ratios
of 0.8, 1.0, and 1.2 are marked in each image). Microspherical particles with hundreds of micrometers in size were well generated at
low magnification (a), and a few micrometer-sized CPC particles and surrounding alginate are revealed at high magnification (b–d).
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The cell proliferation level, as assessed by the MTS
method (Figure 5(a)), showed an ongoing increase in
cell population with time. When grown on the micro-
carriers, cells were at the same level as the tissue cul-
ture plastic dish, which is used as a positive control.
The results suggest that the developed CPC–alginate
microcarriers are cell compatible and would be useful
as a three-dimensional (3D) scaﬀold for bone regener-
ation. Furthermore, the eﬀect of the composite micro-
carriers on osteogenic diﬀerentiation was assessed by
means of ALP activity produced by the cells after cul-
ture for 7 and 14 days (Figure 5(b)). At day 7, the
ALP level of cells grown on the microcarriers was
comparable to that on the control. After 14 days,
the ALP level on the microcarriers increased substan-
tially, whereas that on the control only slightly
increased. These results confirmed the potential role
of the CPC–alginate composite microcarriers in pro-
viding appropriate scaﬀold conditions for cells to
undergo osteogenic development under the osteogenic
medium conditions. It is considered that the trans-
formed bone-mineral like apatite phase may be an
excellent substrate condition for the osteoblastic dif-
ferentiation with respect to the culture dish.
Moreover, the expected release of ions may also be
possible stimulators of cell diﬀerentiation, and more
in-depth studies will be needed as further work.
Apart from the compositional merit of the CPC–
alginate solid microcarriers, we aimed to develop the
spheres to have a porous structure, which is considered
to be eﬀective to hold tissue cells within the spheres and
support their multiplication for tissue engineering due
to their large surface area to volume ratio. The solidi-
fied microcarriers were frozen and lyophilized after
being soaked in water. Figure 6 shows the SEM
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Figure 3. (a,b) Surface morphological change of microcarriers
(CPC/alginate¼ 1.0) during immersion in the body simulating
medium for 7 days shown at different magnifications (a,b) and
the XRD patterns before and after immersion for 7 days,
showing the development of HA phase, due to the transform-
ation of a-TCP.
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Figure 2. Measurement of sizes of microcarriers with
different CPC/alginate compositions: (a) size distribution and
(b) average size.
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image of the porous microcarriers. Particulates of a few
hundreds of micrometers were obtained after the lyoph-
ilization process; however, the shape was not isotropic,
but somewhat irregular. More noticeable was the for-
mation of a large amount of macropores throughout
the spheres, with pore sizes of 20–50 mm, which also
appeared interconnected, as shown in the morphology
of the fragmented sphere. By adopting a simple process,
that is, soaking in water followed by lyophilization, the
dense microcarriers could be developed with a porous
structure. The frozen ice crystals were sublimated to
leave interconnected pores throughout the spheres.
The size of the pores can be tuned by varying the freez-
ing temperature, i.e., with increasing temperature, the
pore size increases.17–19 Herein, the developed pore
sizes were about 20–50mm at the freezing temperature
of #20"C. The beneficial eﬀects of the pore structure
generated in the microcarriers are obvious based on
previous works that report a high-loading capacity of
cells for use as tissue engineering scaﬀold.2,6,20,21
Further work is needed regarding the applications of
this porous microcarrier.
Conclusions
CPC–alginate microcarriers were newly developed as a
3D matrix for bone repair. The self-setting reaction of
the composition facilitated ease-of-sphere formation at
mild conditions. The resultant bone-mineral-like apa-
tite phase transformed from the initial CPC powder is
considered to provide excellent substrate conditions for
bone-associated cells. Preliminary cellular study proved
that the spheres were favorable for cells to adhere,
spread, and proliferate on, and to undergo osteogenic
diﬀerentiation. Taken together, the newly developed
CPC–alginate microcarriers are considered to be
useful as a 3D matrix for bone regeneration.
Figure 4. Cell growth morphology grown on the CPC/alginate
microcarriers during culture for 3 days, taken from SEM.
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Figure 5. (a) Cell proliferation behavior on the spheres during
14 days, as compared with those on the culture dish control,
showing an ongoing cell growth, and (b) ALP activity of the cells
grown on the microcarriers significantly increased at 14 days,
compared to control. (*p< 0.05 by ANOVA for n¼ 3).
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